Immunization Graphs - Gene's Green Book

1 downloads 136 Views 1MB Size Report
Sources: Data for years 1919-1967 Mortality Statistics: Deaths Registered in England &. Wales; UK Office for Nationa
Immunization Graphs: Natural Infectious Disease Declines; Immunization Effectiveness; and Immunization Dangers

Prepared by: Raymond Obomsawin Ph.D. December, 2009

FIGURE SET I. Natural Infectious Disease Declines Preceding Public Immunization Efforts Figures one (1) through eleven (11) graphically illustrate that in North America, Europe, and the South Pacific , major declines in life-threatening infectious diseases occurred historically either without, or far in advance of public immunization efforts for specific diseases as listed. This provides irrefutable evidence that vaccines are not necessary for the effective elimination of a wide range of infectious diseases

800.00

FIGURE 1 – CANADA MEASLES REPORTED INCIDENCE (1935-1983)

700.00 Note: Incidence data was unavailable in the period spanning 1959-1968 600.00

500.00

400.00

Measles Vaccines Introduced Live 1963 / Inactivated 1964

300.00

200.00

100.00

0.00

1935

1947

1959

1971

1983

Source: Adapted from: Public Health Agency of Canada, Figure 8 – Measles Reported Incidence Canada. http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-meas-roug-eng.php

1,200.00

FIGURE 2 - ENGLAND & WALES MEAN ANNUAL MEASLES MORTALITY CASES CHILDREN UNDER 15 (1850-1965)

1,000.00

800.00

Measles Vaccination Begins

600.00

400.00

200.00

0.00

1850

1875

1900

1925

1950

1965

Source: McKeown, T., The Role of Medicine: Dream, Mirage or Nemesis?; Basil Blackwell; Oxford, UK; 1979; p. 105; & Waltzkin, H., in The Relevance of Social Science for Medicine; Springer; 1st edition, Dec. 31, 1980

0.14

FIGURE 3 - ENGLAND SCURVY & MEASLES PARALLEL MORTALITY RATES PER 100,000 (1919-1967)

0.12

0.1

0.08

0.06

SCURVY

MEASLES

0.04

Measles Vaccination Begins 0.02

0 1919

1925

1931

1937

1943

1949

1955

1961

1967

Sources: Data for years 1919-1967 Mortality Statistics: Deaths Registered in England & Wales; UK Office for National Statistics, 1997.

FIGURE 4 – CANADA TUBERCULOSIS MORTALITY RATES PER 100,000 (1880-1960)

200.00

180.00

160.00

140.00

120.00

100.00

BCG Vaccination Introduced Between 1948-1954 (Depending on Prov. or Terr.)

80.00

60.00

40.00

20.00

0.00

1880

1900

1924

1930

1936

1942

1948

1954

1960

Source: Table based on data at: Timeline of TB in Canada http://www.lung.ca/tb/tbhistory/timeline/; http://www.thecanadianencyclopedia.com/index.cfm?PgNm=TCE&Params=A1ARTA0008151 Public Health Agency of Canada: http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-bcg-eng.php; and PHAC on BCG usage in Canada: http://www.phac-aspc.gc.ca/tbpc-latb/bcgvac_1206-eng.php

200.00

FIGURE 5 – UNITED STATES TUBERCULOSIS MORTALITY RATES PER 100,000 INFANTS (1900-1960)

180.00

160.00

140.00

120.00

100.00

No Vaccination for Tuberculosis Adopted in the USA

80.00

60.00

40.00

20.00

0.00

1900

1910

1920

1930

1940

1950

1960

Source: John H. Dingle; Life and Death in Medicine; Scientific American; 1973; p. 56.

FIGURE 6 - NEW ZEALAND TUBERCULOSIS MORTALITY RATES PER MILLION (1880-1960)

1,400.00

1,200.00

1,000.00

800.00

600.00

BCG Vaccination Introduced

400.00

200.00

0.00

1880

1890

1900

1910

1920

1930

1940

1950

1953

1960

Source: Director General Annual Mortality Reports Covering 1872-1960, New Zealand Parliamentary Journals for the Years Specified.

16.00

FIGURE 7 – UNITED STATES MEAN ANNUAL PERTUSSIS MORTALITY RATES PER 100,000 (1918-1960)

14.00

12.00

10.00

8.00

Pertussis Vaccination Introduced 6.00

4.00

2.00

0.00

1918

1924

1930

1936

1942

1948

1954

1960

Source: Data derived from: Vital Statistics of the United States 1937-1960; and Historical Statistics of the United States: Colonial Times to 1970 Part 1 Ch. B Vital Statistics and Health and Medical Care, pp. 44-86H.

FIGURE 8 - ENGLAND & WALES MEAN ANNUAL PERTUSSIS MORTALITY CASES CHILDREN UNDER 15 (1850-1965) 1,400.00

Children under 15 1,200.00

1,000.00

800.00

Pertussis Vaccination Introduced 600.00

400.00

200.00

0.00

1850

1875

1900

1925

1950

1965

Source: Thomas McKeown, The Role of Medicine: Dream, Mirage or Nemesis?; Basil Blackwell; Oxford, UK; 1979; p. 103

0.18

FIGURE 9 - ENGLAND SCURVY & PERTUSSIS PARALLEL MORTALITY RATES PER 100,000 (1919-1967)

0.16

0.14

0.12

0.1

0.08

0.06

SCURVY

PERTUSSIS

0.04

0.02

Pertussis Vaccination Begins 0 1919

1925

1931

1937

1943

1949

1955

1961

1967

Sources: Data for years 1919-1967 Mortality Statistics: Deaths Registered in England & Wales; UK Office for National Statistics, 1997.

12.00

FIGURE 10 – UNITED STATES MEAN ANNUAL SCARLET FEVER MORTALITY RATES PER 100,000 (1910-1958)

10.00

8.00

6.00

No Vaccination for Scarlet Fever Adopted in the USA 4.00

2.00

0.00

1910

1916

1922

1928

1934

1940

1946

1952

1958

Source: Data derived from - Vital Statistics of the United States 1937-1960; and Historical Statistics of the United States: Colonial Times to 1970 Part 1 Ch. B Vital Statistics and Health and Medical Care, pp. 44-86H.

FIGURE 11 – UNITED STATES ANNUAL INFLUENZA MORTALITY RATES PER 100,000 (1933-1965) 180.00

160.00

140.00

120.00

100.00

80.00

Influenza vaccination first widely administered in the U.S. in the late 1980s.

60.00

40.00

20.00

0.00

1933

1937

1941

1945

1949

1953

1961

1965

Source: Doshi, P., Trends in Recorded Influenza Mortality: United States 1900-2004, American Journal of Public Health, May 2008, vol. 98, no. 5, p. 941.

FIGURE SET II. Immunization Effectiveness Figures eleven (12) through twenty-four (24) graphically illustrate that immunization is not by any means a proven and foolproof measure for protection from various infectious disease conditions. It is often inconsequential epidemiologically, and in some cases it is shown to actually worsen health-care outcomes.

Figure 12

Children Under 2 Yrs of Age

Inactivated Influenza Vaccine

0% Effective

Source: Cochrane Collaboration Database of Systematic Reviews, (John Wiley & Sons, Ltd.) 2006 (1) Article No. CD004879 – Covers 51 Studies on 260,000 children

Figure 13

Elderly Living in Communities & Group Homes

Inactivated Influenza Vaccine

Little or No Effectiveness

Source: Cochrane Collaboration Database of Systematic Reviews, (John Wiley & Sons, Ltd.) 2006 (3) Article No. CD004876 – Covers 64 Studies, over 40 years of infuenza vaccination and see: http://www.bmj.com/cgi/content/full/333/7574/912

Figure 14

BCG for Tuberculosis Note: Tuberculosis higher among two (2) dose Vaccinated versus Placebo Group

0% Effective

Source: Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi; The Lancet, Volume 348, Issue 9019, Pages 17 - 24, 6 July 1996

Figure 15

BCG for Tuberculosis Note: In years 0-2.5 the vaccinated had double the incidence of Tuberculosis versus Placebo Group

0% Effective

Source: Double blind randomized controlled trial of BCG’s effectiveness on 250,000 subjects Tuberculosis Research Centre (ICMR), Chennai, India: Indian Journal of Medical Research, 110, August 1999, pp. 56-69.

Figure 16

MUMPS OUTBREAK IN HIGHLY VACCINATED POPULATION

92% Vaccinated

8%

8% Unvaccinated 92%

2006 Iowa Source: Center for Disease Control , MMWR 55 (20); May 26, 2006; pp. 559-63.

Figure 17

CHICKENPOX OUTBREAK IN HIGHLY VACCINATED POPULATION 14%

86% Vaccinated 14% Unvaccinated 86%

2001 Oregon Source: Pediatrics - Vol. 113; No. 3; pp. 455-459; (2004)

Figure 18

PERTUSSIS OUTBREAK IN HIGHLY VACCINATED POPULATION 10%

90% Vaccinated 10% Unvaccinated 90%

1993 Ohio

Source: N.Z. Miller; Vaccine Safety Manual; N.A. Press, Sante Fe, New Mexico; p. 140; (2008) (Refers to CDC & Official Surveillance data)

Figure 19

MEASLES OUTBREAK IN HIGHLY VACCINATED POPULATION 1%

99% Vaccinated 1% Unvaccinated 99%

1985 Texas Source: New England Journal of Medicine Vol. 316; No. 13; pp. 771-774; (1987)

FIGURE 20 - NIGERIA DIPHTHERIA REPORTED CASES (1973-1982)

1,000.00

800.00

600.00

EPI Begins Diphtheria Vaccine 400.00

200.00

0.00 1973

1974

1975

1976

1977

1978

1979

1980

1981

Source: E. Ekanem; A 10-Year Review of Morbidity from Childhood Preventable Diseases in Nigeria: How Successful is the Expanded Programme of Immunization (EPI)?; Journal of Tropical Pediatrics, Vol. 34; No. 6; UK; 1988; pp. 323-328.

1982

FIGURE 21- NIGERIA WHOOPING COUGH CASE RATES PER 100,000 (1973-1982) 500.00

400.00

300.00

EPI Begins Pertussis Vaccine 200.00

100.00

0.00 1973

1974

1975

1976

1977

1978

1979

1980

1981

Source: E. Ekanem; A 10-Year Review of Morbidity from Childhood Preventable Diseases in Nigeria: How Successful is the Expanded Programme of Immunization (EPI)?; Journal of Tropical Pediatrics, Vol. 34; No. 6; UK; 1988; pp. 323-328.

1982

FIGURE 22 - DOMINICAN REPUBLIC MEASLES CASE RATES PER 100,000 (1978-1989) 180.00

160.00

140.00

120.00

100.00

80.00

60.00

EPI Begins Measles Vaccine

40.00

20.00

0.00 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 Sources: Data for years 1978-1987 Taken from UNICEF Evaluation Publication No. 6, Santo Domingo, Dominican Republic, May 27, 1988; and Data for years 1988-1989 from personal communication from PAHO, EPI Unit, Aug. 21, 1990.

FIGURE 23 - DOMINICAN REPUBLIC DIPHTHERIA CASE RATES PER 100,000 (1978-1987) 7.00

6.00

5.00

4.00

3.00

EPI Begins Diphtheria Vaccine

2.00

1.00

0.00 1978

1979

1980

1981

1982

1983

1984

1985

1986

1987

Source: Data for years 1978-1987 Taken from UNICEF Evaluation Publication No. 6, Santo Domingo, Dominican Republic, May 27, 1988.

FIGURE 24 - DOMINICAN REPUBLIC PERTUSSIS CASE RATES PER 100,000 (1978-1989) 20.00

18.00

16.00

14.00

12.00

10.00

8.00

EPI Begins Pertussis Vaccine

6.00

4.00

2.00

0.00 1978

1979

1980

1981

1982

1983

1984

1985

1986

1987

1988

1989

Sources: Data for years 1978-1987 Taken from UNICEF Evaluation Publication No. 6, Santo Domingo, Dominican Republic, May 27, 1988; and Data for years 1988-1989 from personal communication from PAHO, EPI Unit, Aug. 21, 1990.

FIGURE SET III. Immunization Dangers Figures twenty-five (25) through thirty five (35) graphically illustrate that increases in the number of governmental mandated vaccine doses correlates with significant increases in death rates for children under the age of five (5); and that the practice is linked to sudden infant death syndrome; various degenerative diseases, including diabetes; and appears to cause general immune system impairment in infants and children. Evidence also points to the practice of immunization as a principal factor in the recent massive increases in neurodegenerative conditions such as autism in children.

FIGURE 25 - COUNTRIES & NUMBER OF VACCINE DOSES MANDATED TO AGE 5 UNDER AGE 5 MORTALITY RATES FOR 2007 9 8

Under Age 5 Mortality per 1,000 Live Births 7

Mortality Increase Trendline 6 5 4 3 2 1 0

Under Age 5 Mortality statistics derived from: World Health Organization – World Health Statistics 2009 Report http://www.who.int/whosis/whostat/EN_WHS09_Table1.pdf & Govt. Mandated Vaccines figures derived from: Generation Rescue Inc. 2009 http://www.generationrescue.org/documents/SPECIAL%20REPORT%20AUTISM%202.pdf

FIGURE 26 - UNDER AGE 5 INFLUENZA DEATHS BEFORE AND AFTER U.S. CDC MANDATES FLU VACCINES IN EARLY CHILDHOOD 90 80

Influenza Deaths Children Under Age 5 70

60 50 40 30 20 10

Latter half of 2002 C DC Mandates Early Childhood Flu Vaccines in USA

0

1999

2000

2001

2002

2003

Under Age 5 Influenza Mortality statistics derived from: Center for Disease Control Vital Statistics Reports covering Years 1999-2003 reported in Miller, N.Z., Vaccine Safety Manual, New Atlantean Press, Sante Fe, New Mexico, 2008, p. 97.

FIGURE 27 - PERTUSSIS VACCINE & SUDDEN INFANT DEATH SYNDROME 80% 70% 60% 50% 40%

Post-Pertussis Vaccination 70% of SIDS Deaths Occurred Within 3 Weeks

30% 20% 10% 0% 0.5

1

3

7

14

21

Days Post-Vaccination 2/3 of 103 infants had been vaccinated with pertussis prior to death, of which 6.5% died within 12 hours; 13% within 24 hours; 26% within 3 days; 37%, 61% & 70% within 1, 2, & 3 weeks respectively. Source: Torch W., Neurology - 32 (4 – Pt. 2) A, 1982, pp. 169-170.

4 3.5

FIGURE 28 - MEASLES VACCINE & INFLAMMATORY BOWEL DISEASES

3 2.5

Unvaccinated

2

Vaccinated

1.5 1 0.5 0

Ulcerative Colitis

Crohn's Disease

Source:The Lancet - Vol. 345; 8957; 1995, pp. 1062-1063.

Average Incidence First Five (5) years of Life

Fever >40°

Nederlands Vereniging Kritisch Prikken 2004 Survey Findings

Ear Infections

FIGURE 29 Inflammation of the Throat

Fully Vaccinated

Aggressive Behaviour Events

No Vaccinations

Convulsions/ Collapse Antibiotics Administered 0

0.5

1

1.5

2

2.5

Absolute Incidence N=543

Baby Cries Often Nederlands Vereniging

Kritisch Prikken 2004 Survey Findings

Sickly

Eczema Asthma/ Chronic Lung Disease

FIGURE 30 Fully Vaccinated

Allergic Reactions

No Vaccinations

Aggressive Behaviour Difficulty Sleeping 0

20

40

60

80

100

120

140

160

180

Absolute Incidence (Non-Vaccinated in Relation to Vaccinated to N = 312 Per Group

BCG Mandated in Schools & Diabetes Rates Iceland

FIGURE 31

Luxembourg Spain, Catalonia

NO BCG VACCINATIONS BCG VACCINATIONS

Belgium Netherlands Spain, Madrid

Source: Infectious Disease in Clinical Practice - No. 6, pp. 449-454; (1997)

England N. Ireland Scotland Denmark Norway

0

20

25

Cumulative Incidence IDDM/1,000,000 UK

140

Incidence - Insulin Dependant Diabetes Mellitus FIGURE 32 Percentage - Pertussis Immunization Coverage

120 100

5 10 15 Type 1 per 1000,000 – Children 0-14

Source: Journal of Pediatric Endocrinology & Metabolism, 16, pp. 495-508; (2003)

80 60 40 20 0 1978/74

1979/75

1980/76

1981/77

1982/78

1983/79

1984/80

1985/81

1986/82

1987/83

1988/84

1985/86

FIGURE 33

http://childhealthsafety.wordpress.com/2009/06/03/japvaxautism/ Figure based on: Kihei Terada et. al.; Alterations in epidemics and vaccination for measles during a 20 year period and a strategy for elimination in Kurashiki City, Japan; Kawasaki Medical School 2002 Mar; 76 (3):pp. 180-4. Correlated with: H. Honda et. al,; No effect of MMR withdrawal on the incidence of autism: a total population study; Journal of Child Psychology & Psychiatry; June 2005 (6); pp.572-579

25

20

FIGURE 34 18

20

16

14

15

12

10

Vaccine Mercury Burden & Autism Rate California, USA

10

8

6

1991-1997 Surveys

5

4

2

0 Rate

0

1991

1992

1993

1994

1995

1996

1997

Rate of Autism per 10,000 Vaccine Mercury Exposure (x 10 = Micrograms) Source: Adapted from Blaxil, M., Vaccine Mercury Burden & Autism Risk (US) IOM 7/2001, http://www.healing-arts.org/children/marksslide_files/slide0003.htm

VSD: Generation Zero

FIGURE 35 Source: http://www.evidenceofharm.com/UCSD.ppt#363,27,VSD: Generation Zero